Plain-English translation of NCT06543537 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new communication tool called CASI (Collaborative Agenda-setting Intervention) designed to improve conversations between ovarian cancer patients, their caregivers, and their doctors. The tool helps everyone prepare for clinic visits and make sure the most important topics get discussed. Researchers want to see if using this tool helps patients and their care teams communicate better about cancer treatment.
Many patients with cancer feel they don't have enough time to discuss all their concerns during doctor visits, or that their most pressing questions don't get addressed. This study aims to see whether a communication tool that helps patients and doctors plan visits ahead of time can lead to better conversations and more satisfying care.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either use the new communication tool or receive standard cancer care. If you use the new tool, you'll complete a brief online form on a computer or mobile device about one week before each clinic visit to help prepare your questions and concerns, then attend three recorded clinic visits where you'll use the tool with your doctor. If you're in the standard care group, you'll simply have your regular clinic visits audio recorded. The entire study lasts about 12 weeks, with several recorded visits and questionnaires along the way.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
United States